| ALS | amyotrophic lateral sclerosis |
| CNS | central nervous system |
| fALS | familial amyotrophic lateral sclerosis |
| sALS | sporadic amyotrophic lateral sclerosis |
| FDA | Food and Drug Administration |
| iPSCs | induced pluripotent stem cells |
| ESCs | embryonic stem cells |
| MNs | motor neurons |
| hiPSCs | human induced pluripotent stem cells |
| iPSCs-MNs | induced pluripotent stem cells derived motor neurons |
| ESCs-MNs | embryonic stem cells derived motor neurons |
| NPCs | neural progenitor cells |
| iPSCs-NPCs | induced pluripotent stem cells derived neural progenitor cells |
| NSCs | neural stem cells |
| iPSCs-NSCs | induced pluripotent stem cells derived neural stem cells |
| NMJ | neuromuscular junction |
| SOD1 | superoxide dismutase 1 |
| C9orf72 | chromosome nine open reading frame 72 |
| TARDBP | TAR DNA binding protein |
| FUS | fused in sarcoma |
| NfH | neurofilament heavy chain |
| NfL | neurofilament light chain |
| CSF | cerebrospinal fluid |
| HD-MEAs | high density microelectrode-arrays |
| DPR | dipeptide repeat |
| TDP-43 | TAR DNA binding protein 43 |
| RNAP II | RNA polymerase II |
| EAAT2 | excitatory amino acid transporter 2 |
| SG | stress granule |
| G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 |
| Il-1α | interleukin 1α |
| TNF | tumor necrosis factor |
| C1q | complement component 1, subcomponent q |
| ROPI | ropinirole |
| HDAC | histone deacetylase |
| FTD | frontotemporal dementia |
| STAT3 | signal transducer and activator of transcription 3 |
| TGF-β | transforming growth factor-β |